The company operates as a holding company, currently investing in a pharmacy business that sells pharmaceuticals, cosmetics, dietary supplements, medical equipment, and various health products. It also engages in research and development with external research teams and outsources manufacturing to distribute health products and innovations.
| 6M25 | 6M24 | 2024 | 2023 |
|---|
| Revenues | 1,138.87 | 966.91 | 2,017.89 | 1,659.31 |
| Expenses | 1,087.92 | 926.54 | 1,916.05 | 1,558.59 |
| Net Profit (Loss) | 37.26 | 30.30 | 78.26 | 74.68 |
| Assets | 1,490.51 | 1,429.58 | 1,499.06 | 1,382.35 |
| Liabilities | 521.73 | 472.03 | 493.23 | 414.29 |
| Shareholders' Equity | 968.78 | 957.55 | 1,005.82 | 968.05 |
| Operating | 83.59 | 37.46 | 88.76 | 91.26 |
| Investing | -119.62 | -165.20 | -171.89 | 177.28 |
| Financing | -99.09 | -60.16 | -83.01 | -80.08 |
| EPS (Baht) | 0.14 | 0.11 | 0.29 | 0.27 |
| GP Margin (%) | 23.74 | 22.43 | 23.51 | 23.06 |
| NP Margin (%) | 3.27 | 3.13 | 3.88 | 4.50 |
| D/E Ratio (x) | 0.54 | 0.49 | 0.49 | 0.43 |
| ROE (%) | 8.85 | 8.11 | 7.93 | 7.82 |
| ROA (%) | 8.01 | 7.42 | 7.08 | 7.50 |
The company group has continuous branch expansion plans, focusing on the Bangkok metropolitan area and surrounding provinces due to their high market value. There is a plan to open 14 branches in 2025. In addition, the company group plans to add new innovative product items under its own brand and expand distribution channels outside the company network.
- Adheres to a policy of conducting business with fairness, respect for the law, and transparency.
- Committed to strictly complying with regulations and laws.
- Complies with international labor laws and regulations, as well as fundamental human rights.
- Prioritizes customer responsibility by selecting quality products and services, providing accurate and up-to-date information to customers, and maintaining customer confidentiality.
- Has a policy of promoting environmental care by reducing the use of plastic bags and cardboard boxes, implementing an ERP system to reduce paper usage, and piloting the use of the e-Tax system with capable partners.
- Recognizes the importance of strong communities and sustainable social development by participating in and promoting various activities in public health, education, and Buddhism.
- Participates in the "Pharmaceutical Blister Pack Recycling Program" to promote sustainable waste management. The group's pharmacies serve as collection points for foil blister packs, which are then processed to create value and benefit from waste.
- Collaborates with iRedcross on the "Parkinson's Support Project" to support the identification and care of Parkinson's patients, helping them receive appropriate care and improve their quality of life.
Invests in pharmaceutical retail and research and development businesses in collaboration with external research teams to distribute innovative health products. Owns four pharmacy brands with 67 branches in Bangkok and surrounding areas, and three innovative product brands: "Prime" for dietary supplements, "Besuto" for health and hygiene products, and "Q" health products from herbal innovations.
During 6M2025, the Group recorded total sales revenue of THB 1,118.10 million, marking an 18.02% YOY increase. The majority of revenue continued to come from retail sales, accounting for 99.10% of total revenue.
By product category, all segments showed YOY growth. The External health products segment posted the highest growth at 31.84% YOY, followed by Consumer goods at 18.40% YOY.
Other income rose by 35.92% YOY, mainly driven by the expansion of branches and sales areas, which led to increased service income. Additionally, revenue from External health products continued to grow steadily.
- As of June 30, 2025, the Group operated a total of 67 pharmacy branches, with 4 new branches opened and the closure of the “Vitamin Club” branch at Central Pinklao at the end of April. This closure was part of a business restructuring initiative in the Bangkok Metropolitan Region.
- During 6M2025, the Group launched 3 new SKUs which are Herbal Mouth Spray Q Brand, Herbal Nasal Spray Q Brand and Prime Probio 14 Plus 30s (dietary supplement).
- In April 2025, Healthiness Co., Ltd. showcased the “Q” brand products at the World Expo Osaka 2025 in Japan, and later at the 20th National Herbal Expo held in Bangkok from July 2–6, 2025, aiming to enhance brand awareness and expand the market for herbal health products.
- Since founding the drugstore 30 years ago, the Group has sourced from two major distributors. The partnership has gone well. However, the Group has regularly reviewed new suppliers to ensure it secures sufficient products.
- In terms of competition risk, the Group focuses on expanding branches to strategic locations in Bangkok and having pharmacists stationed at all branches to guarantee superior quality of services.
- The Group is widely recognized in pharmacist professional group, as it has been offering internship programs for pharmaceutical students from leading universities for years. This has efficiently mitigated the risk of pharmacist shortage.
- Silver Medal, Innovation: Cell Matrix Technology - Prime VISION INVENTION GENEVA EVALUATION DAYS; March 28, 2022
- Gold Medal Award, Innovation: Prime MOVX2 - 2022 Japan Design, Idea & Invention Expo; July 1-3, 2022
- Gold Medal Award, Innovation: Prime KIN - 2024 Japan Design, Idea & Invention Expo; July 5-7, 2024
- Gold Medal Award, Innovation and Invention: Prime Bioenhancz - 2024 PRIX EIFFEL, Idea & Invention Expo; November 12, 2024
- Special Award, Innovation: Prime Bioenhancz - Innovation Initiative Co-operative Inc. (CANADA); November 12-13, 2024
- Silver Medal Award, Innovation and Invention: Q Herbal Mouth Spray - 2024 PRIX EIFFEL, Idea & Invention Expo; November 12-13, 2024
| as of 30/06/25 | HL | SERVICE | mai |
|---|---|---|---|
| P/E (X) | 23.22 | 63.41 | 60.02 |
| P/BV (X) | 1.81 | 1.59 | 1.15 |
| Dividend yield (%) | 2.49 | 3.34 | 3.94 |
| 30/06/25 | 30/12/24 | 28/12/23 | |
|---|---|---|---|
| Market Cap (MB) | 1,890.40 | 2,774.40 | 2,828.80 |
| Price (B/Share) | 6.95 | 10.20 | 10.40 |
| P/E (X) | 23.22 | 36.14 | 35.81 |
| P/BV (X) | 1.81 | 2.85 | 3.02 |